Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.380
-0.050 (-1.46%)
At close: Apr 28, 2026, 4:00 PM EDT
3.390
+0.010 (0.30%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.39 billion as of April 28, 2026. Its market cap has increased by 38.79% in one year.
Market Cap
1.39B
Enterprise Value
1.14B
1-Year Change
38.79%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $1.39B, an increase of 469.27%. That is a compound annual growth rate of 16.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.41B | 30.39% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.49B |
| Biohaven | 1.49B |
| Agios Pharmaceuticals | 1.48B |
| Bicara Therapeutics | 1.48B |
| Precigen | 1.46B |
| Ardelyx | 1.46B |
| Maze Therapeutics | 1.43B |
| Viridian Therapeutics | 1.42B |